Suppr超能文献

FGL-1/LAG-3轴与酒精性肝炎病程相关:初步报告

The FGL-1/LAG-3 Axis is Associated With Disease Course in Alcohol-associated Hepatitis: A Preliminary Report.

作者信息

Pedersen Lasse, Eriksen Lotte L, Brix Frederik H, Vilstrup Hendrik, Deleuran Bent, Sandahl Thomas D, Støy Sidsel

机构信息

Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.

Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

出版信息

J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102424. doi: 10.1016/j.jceh.2024.102424. Epub 2024 Oct 10.

Abstract

BACKGROUND

Alcohol-associated hepatitis (AH) has a short-term mortality rate of up to 40% primarily related to impaired hepatocyte regeneration and uncontrolled liver inflammation. The acute phase protein fibrinogen-like protein 1 (FGL-1) produced by hepatocytes stimulates hepatocyte proliferation by autocrine signaling. FGL-1 also is a ligand for the inhibitory T cell receptor lymphocyte activation gene 3 (LAG-3). In these ways, FGL-1 and LAG-3 have beneficial interactions that could be interrupted in AH.

AIMS

We aimed to characterize FGL-1 and LAG-3 in patients with AH and describe their relationship with the disease state and course.

METHODS

Thirty-two patients with AH were included at diagnosis and followed up for 3 years. We measured the hepatic gene expression of FGL-1 and LAG-3 using RNA sequencing, plasma FGL-1 and soluble (s)LAG-3 using ELISA, and LAG-3CD8 T cells using flow cytometry. Healthy persons (HC) and patients with stable alcohol-associated cirrhosis served as controls.

RESULTS

At diagnosis of AH, liver FGL-1 mRNA was increased when compared to HC, whereas plasma FGL-1 was unchanged. In contrast, liver LAG-3 mRNA was reduced in AH. Plasma sLAG-3 levels and the frequency of LAG-3CD8 T cells were as in HC. However, those patients who had the lowest plasma FGL-1 and the lowest frequency of LAG-3CD8 T cells at diagnosis had the highest disease severity and mortality.

CONCLUSIONS

Our data suggest that an impaired FGL-1/LAG-3 axis may be involved in the pathogenesis and course of AH.

摘要

背景

酒精性肝炎(AH)的短期死亡率高达40%,主要与肝细胞再生受损和无法控制的肝脏炎症有关。肝细胞产生的急性期蛋白纤维蛋白原样蛋白1(FGL-1)通过自分泌信号刺激肝细胞增殖。FGL-1也是抑制性T细胞受体淋巴细胞激活基因3(LAG-3)的配体。通过这些方式,FGL-1和LAG-3具有有益的相互作用,而这种相互作用在AH中可能会被中断。

目的

我们旨在描述AH患者中FGL-1和LAG-3的特征,并阐述它们与疾病状态和病程的关系。

方法

32例AH患者在诊断时被纳入研究,并随访3年。我们使用RNA测序测量FGL-1和LAG-3的肝脏基因表达,使用酶联免疫吸附测定(ELISA)测量血浆FGL-1和可溶性(s)LAG-3,使用流式细胞术测量LAG-3⁺CD8⁺ T细胞。健康人(HC)和稳定期酒精性肝硬化患者作为对照。

结果

在AH诊断时,与HC相比,肝脏FGL-1 mRNA增加,而血浆FGL-1没有变化。相反,AH患者肝脏LAG-3 mRNA减少。血浆sLAG-3水平和LAG-3⁺CD8⁺ T细胞频率与HC相同。然而,那些在诊断时血浆FGL-1最低且LAG-3⁺CD8⁺ T细胞频率最低的患者疾病严重程度和死亡率最高。

结论

我们的数据表明,FGL-1/LAG-3轴受损可能参与了AH的发病机制和病程。

相似文献

1
The FGL-1/LAG-3 Axis is Associated With Disease Course in Alcohol-associated Hepatitis: A Preliminary Report.
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102424. doi: 10.1016/j.jceh.2024.102424. Epub 2024 Oct 10.
2
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
8
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Direct-acting antivirals for chronic hepatitis C.
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.

本文引用的文献

1
Cirrhosis-Based Acute-on-Chronic Liver Failure Is Marked by Inflammation and Impaired Liver Regeneration Despite Stat3 Activation.
Gastro Hep Adv. 2022 Apr 29;1(4):520-530. doi: 10.1016/j.gastha.2022.03.005. eCollection 2022.
2
Protective Role of Hepassocin against Hepatic Endoplasmic Reticulum Stress in Mice.
Int J Mol Sci. 2022 Nov 1;23(21):13325. doi: 10.3390/ijms232113325.
3
Recombinant Human HPS Protects Mice and Nonhuman Primates from Acute Liver Injury.
Int J Mol Sci. 2021 Nov 28;22(23):12886. doi: 10.3390/ijms222312886.
4
Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.
Int J Mol Sci. 2021 May 13;22(10):5170. doi: 10.3390/ijms22105170.
6
LAG3's Enigmatic Mechanism of Action.
Front Immunol. 2021 Jan 8;11:615317. doi: 10.3389/fimmu.2020.615317. eCollection 2020.
8
PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.
Cancer Immunol Res. 2019 Nov;7(11):1891-1899. doi: 10.1158/2326-6066.CIR-19-0146. Epub 2019 Sep 4.
9
Current trials and novel therapeutic targets for alcoholic hepatitis.
J Hepatol. 2019 Feb;70(2):305-313. doi: 10.1016/j.jhep.2018.10.026.
10
Alcohol, liver disease and the gut microbiota.
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):235-246. doi: 10.1038/s41575-018-0099-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验